Straumann Holding AG Reports Strong Half-Year Performance

Straumann Holding AG, a leading Swiss company specializing in dental implants, has announced a robust performance for the first half of 2025. The company, headquartered in Basel, reported a half-year revenue of CHF 1.3 billion, reflecting an organic growth of 10.2%. The second quarter alone saw an organic revenue increase of 9.3%, amounting to CHF 667.5 million. The core EBIT margin for the first half stood at 26.6%, or 27.3% when adjusted for the exchange rates of the first half of 2024.

The company’s strong performance has led to the confirmation of its outlook for the full year 2025. Straumann’s stock, traded on the SIX Swiss Exchange, gained approximately 3.1% following the announcement, contributing to a marginal rise in the Swiss market. The benchmark SMI index ended the day with a gain of 16.42 points, or 0.14%, at 11,886.41.

Straumann’s success is underpinned by its global presence, with subsidiaries across Europe and North America, and a diverse product portfolio that caters to the worldwide demand for dental implants. The company’s market capitalization stands at CHF 16,519,558,476, with a price-to-earnings ratio of 36.09057.

As the Swiss market continues to navigate through a period of volatility, Straumann’s positive results have provided a boost to investor confidence. The company’s ability to maintain strong growth and profitability amidst challenging market conditions highlights its resilience and strategic positioning within the health care equipment and supplies sector.

For more detailed information on Straumann’s performance and future outlook, investors and stakeholders are encouraged to visit the company’s website at www.straumann.com .